FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ira Glick

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Schizophrenic Psychology

Organizations

National Institute of Mental Health (U.S.)

Co-author Network

Publications

TOP 3
Joseph P McEvoy; Jackie Johnson; Diana O Perkins; Jeffrey A Lieberman; Robert M Hamer; Richard S E Keefe; Mauricio Tohen; Ira D Glick; Tonmoy Sharma
Insight in first-episode psychosis.
Alan I Green; Jeffrey A Lieberman; Robert M Hamer; Ira D Glick; R E Gur; R S Kahn; Joseph P McEvoy; Diana O Perkins; Anthony J Rothschild; Tonmoy Sharma; Mauricio Tohen; S Woolson; R B Zipursky
Olanzapine and haloperidol in first episode psychosis: two-year data.
Miranda Chakos; Ira D Glick; Alexander Miller; Mark B Hamner; Del D Miller; Jayendra K Patel; Andre Tapp; Richard S E Keefe; Robert A Rosenheck
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ira Glick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Joseph P McEvoy; Jackie Johnson; Diana O Perkins; Jeffrey A Lieberman; Robert M Hamer; Richard S E Keefe; Mauricio Tohen; Ira D Glick; Tonmoy Sharma
Insight in first-episode psychosis.
Psychological medicine 2006;36(10):1385-93.
2006: Alan I Green; Jeffrey A Lieberman; Robert M Hamer; Ira D Glick; R E Gur; R S Kahn; Joseph P McEvoy; Diana O Perkins; Anthony J Rothschild; Tonmoy Sharma; Mauricio Tohen; S Woolson; R B Zipursky
Olanzapine and haloperidol in first episode psychosis: two-year data.
Schizophrenia research 2006;86(1-3):234-43.
2006: Miranda Chakos; Ira D Glick; Alexander Miller; Mark B Hamner; Del D Miller; Jayendra K Patel; Andre Tapp; Richard S E Keefe; Robert A Rosenheck
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
Psychiatric services (Washington, D.C.) 2006;57(8):1094-101.
2005: Stephen M Strakowski; Jacqueline Johnson; Melissa P DelBello; Robert M Hamer; Alan I Green; Mauricio Tohen; Jeffrey A Lieberman; Ira D Glick; Jayendra K Patel
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
Schizophrenia research 2005;78(2-3):161-9.
2004: George M Simpson; Ira D Glick; Peter Weiden; Steven J Romano; Cynthia O Siu
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
The American journal of psychiatry 2004;161(10):1837-47.
2004: Alan I Green; Mauricio Tohen; Robert M Hamer; Stephen M Strakowski; Jeffrey A Lieberman; Ira D Glick; W Scott Clark
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Schizophrenia research 2004;66(2-3):125-35.
2003: Thomas Stroup; Joseph P McEvoy; Marvin Swartz; Matthew J Byerly; Ira D Glick; Jose M Canive; Mark F McGee; George M Simpson; Michael C Stevens; Jeffrey A Lieberman
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
Schizophrenia bulletin 2003;29(1):15-31.
2001: Kim T Mueser; Anjana Sengupta; Nina R Schooler; Alan S Bellack; Haiyi Xie; Ira D Glick; S J Keith
Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden.
Journal of consulting and clinical psychology 2001;69(1):3-12.
1999: S Charles Schulz; Paul Thompson; M Jacobs; P T Ninan; Delbert Robinson; Peter Weiden; K Yadalam; Ira D Glick; C L Odbert
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
The Journal of clinical psychiatry 1999;60(6):366-72.
1997: Nina R Schooler; S J Keith; J B Severe; S M Matthews; Alan S Bellack; Ira D Glick; W A Hargreaves; John M Kane; P T Ninan; A Frances; M Jacobs; Jeffrey A Lieberman; R Mance; George M Simpson; Margaret G Woerner
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
Archives of general psychiatry 1997;54(5):453-63.
1996: Nina R Schooler; J B Severe; Ira D Glick; W A Hargreaves; Samuel J Keith; Peter Weiden
Transition from acute to maintenance treatment: prediction of stabilization.
International clinical psychopharmacology 1996;11 Suppl 2():85-91.